Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.

Launched by UMRANIYE EDUCATION AND RESEARCH HOSPITAL · Dec 13, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how well a specific pain management technique, called the pericapsular nerve group (PENG) block, works for patients undergoing hip fracture surgery. The study aims to compare this method with a standard pain treatment approach to see which one helps reduce pain after surgery more effectively. Researchers will also check how this technique affects other important factors, such as how quickly patients can move around, how long they stay in the hospital, and whether there are any side effects.

To participate in this trial, individuals must be between 30 and 85 years old and scheduled for hip fracture surgery. However, those who are younger than 30 or older than 85, have serious health issues, have cognitive impairments, have infections at the injection site, are allergic to local anesthetics, or cannot give consent will not be eligible. Participants in the trial can expect to receive either the PENG block or the standard treatment and will be monitored for pain levels and recovery progress during their hospital stay.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who will undergo hip fracture surgery Women and men aged 30-85
• Exclusion Criteria:
• • Patients under 30 years old, over 85 years old
• • American Society of Anesthesiology (ASA) IV,
• • Those with cognitive impairment (alzheimer, dementia, delirium, etc.)
• • Those with application site infection
• • Those who are allergic to local anesthetic substances
• • Patients are non-consenting patients.